Avidity Partners Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,425,000
| Closed | -$35M | – | 102 |
|
|
2023
Q2 | $35M | Sell |
1,425,000
-215,200
| -13% | -$5.28M | 1.22% | 35 |
|
|
2023
Q1 | $38.2M | Buy |
1,640,200
+790,200
| +93% | +$18.4M | 1.27% | 30 |
|
|
2022
Q4 | $21.5M | Buy |
+850,000
| New | +$21.5M | 0.47% | 48 |
|
|
2022
Q3 | – | Sell |
-758,211
| Closed | -$19.3M | – | 106 |
|
|
2022
Q2 | $19.3M | Sell |
758,211
-21,789
| -3% | -$555K | 0.44% | 39 |
|
|
2022
Q1 | $20.1M | Buy |
780,000
+80,000
| +11% | +$2.06M | 0.42% | 52 |
|
|
2021
Q4 | $29.3M | Buy |
700,000
+185,000
| +36% | +$7.75M | 0.62% | 48 |
|
|
2021
Q3 | $22.4M | Buy |
515,000
+353,000
| +218% | +$15.4M | 0.5% | 50 |
|
|
2021
Q2 | $7.66M | Buy |
+162,000
| New | +$7.66M | 0.21% | 80 |
|
|
2020
Q3 | – | Sell |
-620,600
| Closed | -$25.4M | – | 86 |
|
|
2020
Q2 | $25.4M | Buy |
+620,600
| New | +$25.4M | 1.63% | 21 |
|